Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
After finishing at $26.74 in the prior trading day, Veracyte Inc (NASDAQ: VCYT) closed at $26.50, down -0.90%. In other words, the price has decreased by -$0.90 from its previous closing price. On the day, 0.83 million shares were traded.
Ratios:
Our goal is to gain a better understanding of VCYT by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.22 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 26.45. For the most recent quarter (mrq), Quick Ratio is recorded 4.78 and its Current Ratio is at 5.10. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Craig Hallum on March 20, 2025, initiated with a Buy rating and assigned the stock a target price of $45.
On December 05, 2024, Goldman Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $38 to $37.
On November 15, 2024, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $50.Wolfe Research initiated its Outperform rating on November 15, 2024, with a $50 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 07 ’25 when Leite John sold 7,411 shares for $31.66 per share. The transaction valued at 234,630 led to the insider holds 100,249 shares of the business.
JOHN LEITE bought 7,411 shares of VCYT for $240,932 on Mar 07 ’25. On Mar 04 ’25, another insider, ANN MCGUIRE, who serves as the Officer of the company, bought 1,142 shares for $33.56 each.
Valuation Measures:
As of this moment, Veracyte’s Price-to-Earnings (P/E) ratio for their current fiscal year is 63.17, and their Forward P/E ratio for the next fiscal year is 36.88. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.44. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.48 while its Price-to-Book (P/B) ratio in mrq is 1.74.
Stock Price History:
Over the past 52 weeks, VCYT has reached a high of $47.32, while it has fallen to a 52-week low of $19.73. The 50-Day Moving Average of the stock is -11.55%, while the 200-Day Moving Average is calculated to be -24.80%.
Shares Statistics:
A total of 78.31M shares are outstanding, with a floating share count of 77.20M. Insiders hold about 1.42% of the company’s shares, while institutions hold 108.39% stake in the company.
Earnings Estimates
The stock of Veracyte Inc (VCYT) is currently in the spotlight, with 10.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is $0.32, with high estimates of $0.36 and low estimates of $0.3.
Analysts are recommending an EPS of between $1.39 and $1.19 for the fiscal current year, implying an average EPS of $1.3. EPS for the following year is $1.34, with 11.0 analysts recommending between $1.51 and $1.04.
Revenue Estimates
10 analysts predict $120.86M in revenue for the current quarter. It ranges from a high estimate of $123.4M to a low estimate of $116.9M. As of the current estimate, Veracyte Inc’s year-ago sales were $114.43MFor the next quarter, 10 analysts are estimating revenue of $124.21M. There is a high estimate of $129M for the next quarter, whereas the lowest estimate is $121M.
A total of 11 analysts have provided revenue estimates for VCYT’s current fiscal year. The highest revenue estimate was $497.8M, while the lowest revenue estimate was $482.1M, resulting in an average revenue estimate of $491.62M. In the same quarter a year ago, actual revenue was $445.76MBased on 11 analysts’ estimates, the company’s revenue will be $540.14M in the next fiscal year. The high estimate is $557.91M and the low estimate is $508.7M.
